門診癌症治療靜脈輸液市場規模、佔有率和成長分析：按服務類型、癌症類型、實施環境、支付方和地區分類－2026-2033年產業預測

2024 年全球門診癌症治療靜脈輸液市場價值為 225.2 億美元，預計到 2033 年將從 2025 年的 241.9 億美元成長至 428.5 億美元，預測期（2026-2033 年）複合年成長率為 7.42%。

門診癌症靜脈輸液治療市場正經歷顯著成長，這主要得益於化療方式從醫院轉變為門診機構的轉變。技術進步、降低成本的經濟壓力以及醫療保險報銷制度的改革推動了這一轉變。患者現在可以在診所、獨立輸液中心甚至家中接受靜脈輸液治療，這不僅方便了患者獲得治療，也確保了臨床管理。這種方式不僅為患者帶來經濟效益，還透過利用標靶治療和皮下製劑，增強了社區醫生提供服務的能力。癌症診斷數量的增加推動了治療需求的成長，進而促使對輸液基礎設施和預約管理技術的投資增加。生物製藥和單株抗體的日益普及，以及向獨立於醫療機構的報銷策略的轉變，將進一步促進門診服務的擴展，並改善整體護理協調。

推動全球門診癌症輸液市場發展的因素

患者和醫療服務提供者對門診治療日益成長的偏好，是推動門診癌症靜脈輸液治療服務成長的主要動力。這一趨勢凸顯了門診治療的便利性優勢，例如與住院治療相比，減少了旅行和等待時間。因此，醫療服務提供者更有動力透過增加服務能力和製定個人化輸液方案來提升服務品質。此外，保險公司和雇主也越來越支持能夠改善病患體驗並最大限度地減少對日常生活干擾的醫療模式。這種轉變正在推動對專科診所、員工培訓和服務模式的投資，旨在提高醫療服務的可近性，最終促進市場的永續成長。

全球門診癌症輸液市場的限制因素

全球門診癌症輸液市場面臨許多挑戰，主要原因是報銷政策不一致以及門診輸液服務的報銷率不足。這些因素降低了醫療機構發展和擴大專科癌症輸液中心的經濟獎勵。保險公司之間涵蓋範圍的差異，加上核准前要求的不統一，增加了行政負擔，並造成了收入的不確定性。因此，對必要的基礎設施、人員配備和患者支援措施的投資受到阻礙。缺乏可靠的支付模式迫使醫療機構限制諮詢時間和患者數量，這可能會阻礙門診治療的普及，儘管其臨床價值和患者需求都很高，最終抑制了整體市場成長。

全球門診癌症輸液市場趨勢

全球門診癌症輸液市場正呈現出利用遠端醫療進行協同照護的顯著趨勢，徹底改變了病患管理和治療遵從性。透過將線上諮詢與數位平台整合，醫療服務提供者可以遠端無縫監測患者，並在出現副作用時迅速調整治療方案。這種創新方法不僅減少了患者的就醫次數，提高了便利性，還促進了多學科團隊之間的協作，從而改善了治療效果。隨著醫療系統擴大採用與電子健康記錄整合的互通技術，它們能夠最佳化資源分配，提高以患者為中心的高品質腫瘤護理效率。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球門診癌症治療靜脈輸液市場規模：依服務類型分類

• 化療滴注
• 免疫療法滴注
• 標靶治療輸注
• 支持性輸液

全球門診癌症治療靜脈輸液市場規模：依癌症類型分類

• 乳癌
• 肺癌
• 結腸癌
• 血癌
• 其他

全球門診癌症治療靜脈輸液市場規模：依醫療機構分類。

• 醫院門診部
• 獨立靜脈輸液治療中心
• 診所的靜脈輸液治療

全球門診癌症治療靜脈輸液市場規模：依支付方分類。

• 聯邦醫療保險
• 私人保險
• 醫療補助
• 自費

全球門診癌症治療靜脈輸液市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• US Oncology Network（McKesson）
• Oncology Analytics
• American Oncology Network
• CVS Health（Coram）
• Option Care Health
• BioScrip（Option Care）
• Optum Infusion Services
• Amedisys Inc.
• Humana（Home Solutions）
• Gentiva Health Services
• Integrated Oncology Network
• Sarah Cannon Research Institute
• Rocky Mountain Cancer Centers
• Texas Oncology（McKesson）
• New York Cancer & Blood Specialists
• Compass Oncology
• Pacific Cancer Care
• Cancer Care Northwest
• Arizona Oncology（US Oncology）
• Tennessee Oncology

結論與建議

Global Outpatient Oncology Infusion Market size was valued at USD 22.52 Billion in 2024 and is poised to grow from USD 24.19 Billion in 2025 to USD 42.85 Billion by 2033, growing at a CAGR of 7.42% during the forecast period (2026-2033).

The outpatient oncology infusion market is experiencing significant growth fueled by the shift of chemotherapy administration from hospitals to outpatient settings. This transition is propelled by technological advancements, economic pressures for cost reduction, and changes in health plan reimbursements. Patients now receive infusions in physician offices, freestanding infusion centers, or even at home, which streamlines treatment access while ensuring clinical oversight. This approach not only benefits patients financially but also enhances service delivery capacity for community-based physicians by leveraging targeted therapies and subcutaneous formulations. The rising cancer diagnoses create a heightened demand for treatments, prompting investments in infusion infrastructure and scheduling technology. As biologics and monoclonal antibodies gain traction, the push for site-neutral reimbursement strategies will further support outpatient service expansion and improve overall care coordination.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Outpatient Oncology Infusion market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Outpatient Oncology Infusion Market Segments Analysis

Global outpatient oncology infusion market is segmented by service type, cancer type, setting, payer and region. Based on service type, the market is segmented into Chemotherapy Infusion, Immunotherapy Infusion, Targeted Therapy Infusion and Supportive Care Infusions. Based on cancer type, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Hematologic Cancers and Others. Based on setting, the market is segmented into Hospital-Based Outpatient, Freestanding Infusion Centers and Physician Office Infusion. Based on payer, the market is segmented into Medicare, Commercial Insurance, Medicaid and Self-Pay. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Outpatient Oncology Infusion Market

The increasing preference for outpatient care among both patients and healthcare providers is a key factor driving the growth of outpatient oncology infusion services. This trend highlights the benefits of convenience, including reduced travel times and shorter wait periods compared to inpatient treatment. As a result, providers are motivated to enhance their offerings by expanding capacity and customizing infusion schedules. Additionally, insurance payers and employers are increasingly endorsing care models that enhance patient experiences and minimize disruptions. This evolution spurs investment in specialized clinics, staff training, and service models designed to improve accessibility, thereby fostering sustainable market growth.

Restraints in the Global Outpatient Oncology Infusion Market

The Global Outpatient Oncology Infusion market faces significant challenges due to fragmented reimbursement policies and inadequate reimbursement rates for outpatient infusion services, which diminish financial incentives for providers to develop or enhance dedicated oncology infusion centers. The inconsistency of coverage among payers, coupled with varying prior authorization requirements, heightens administrative burdens and creates revenue uncertainty, ultimately discouraging investment in necessary infrastructure, staffing, and patient support initiatives. In the absence of reliable payment models, providers may be compelled to restrict service hours or patient throughput, hindering the adoption of outpatient delivery despite its clinical advantages and patient preferences, consequently stalling overall market growth.

Market Trends of the Global Outpatient Oncology Infusion Market

The Global Outpatient Oncology Infusion market is witnessing a significant trend towards telehealth-enabled coordination of care, revolutionizing patient management and treatment adherence. By integrating virtual consultations and digital platforms, healthcare providers can seamlessly monitor patients remotely, allowing for prompt adjustments in therapies as side effects arise. This innovative approach not only enhances patient convenience by reducing the need for physical office visits but also fosters collaboration among multidisciplinary teams, leading to improved outcomes. As health systems increasingly adopt interoperable technologies aligned with electronic health records, they gain the ability to optimize resource allocation, driving efficiency in delivering high-quality, patient-centered oncology care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Outpatient Oncology Infusion Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Chemotherapy Infusion
• Immunotherapy Infusion
• Targeted Therapy Infusion
• Supportive Care Infusions

Global Outpatient Oncology Infusion Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Hematologic Cancers
• Others

Global Outpatient Oncology Infusion Market Size by Setting & CAGR (2026-2033)

• Market Overview
• Hospital-Based Outpatient
• Freestanding Infusion Centers
• Physician Office Infusion

Global Outpatient Oncology Infusion Market Size by Payer & CAGR (2026-2033)

• Market Overview
• Medicare
• Commercial Insurance
• Medicaid
• Self-Pay

Global Outpatient Oncology Infusion Market Size & CAGR (2026-2033)

• North America (Service Type, Cancer Type, Setting, Payer)
  • US
  • Canada
• Europe (Service Type, Cancer Type, Setting, Payer)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Cancer Type, Setting, Payer)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Cancer Type, Setting, Payer)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Cancer Type, Setting, Payer)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• US Oncology Network (McKesson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncology Analytics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Oncology Network
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health (Coram)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Option Care Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioScrip (Option Care)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum Infusion Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amedisys Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana (Home Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gentiva Health Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated Oncology Network
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarah Cannon Research Institute
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rocky Mountain Cancer Centers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Texas Oncology (McKesson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New York Cancer & Blood Specialists
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compass Oncology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Cancer Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cancer Care Northwest
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arizona Oncology (US Oncology)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tennessee Oncology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations